Jafron Biomedical Co Stock

Jafron Biomedical Co P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Jafron Biomedical Co (300529.SZ) as of Aug 5, 2026 is 15.00. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 17.20 — a change of -12.77% (lower).

P/CF

15.00

YoY

-12.77%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Jafron Biomedical Co is 2026 15.00 . P/CF (Price-to-Cash-Flow Ratio) of Jafron Biomedical Co was 2025 17.20 . It decreases by -12.77% lower compared to the previous year.
Access this data via the Eulerpool API

Jafron Biomedical Co Stock analysis

What does Jafron Biomedical Co do? Jafron Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jafron Biomedical Co stock

P/CF (Price-to-Cash-Flow Ratio) of Jafron Biomedical Co is 15.00 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Jafron Biomedical Co changed from 17.20 to 15.00, representing a -12.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Jafron Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Jafron Biomedical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Jafron Biomedical Co

All Key Metrics — Jafron Biomedical Co